Vicplas Intl    Last:0.083    +0.003

Construction Material & Bio-Medical Outsourcing

Quote below is my earlier post.

Basically i am not a technical guy n cant comment on over bought or over sold.
I am a long term holder and was in the counter long before the wuhan health issues,
Wuhan issues was an add-on for me.

I like the way the medical devices segment was trending. Revenue had jumped
from $24.9 mil in 2017 to $45.0 in 2019. And in 2019, the company had a profit
of $4.2 mil, without the wuhan health issues. It actually doesnt not matter to me
even if there is no wuhan health issues. In fact, i wish that there was no wuhan
health issues. Its cruel n people are suffering and dying. And i pray that the issues
be quickly resolved.

To reiterate, i was not in this counter bcoz of the wuhan issues. I was already vested
before the issues. (See posting below) I went in for the low valuation, potential growth,
excellent dividends. The wuhan health issues was just an add-on.

josephyeo      ( Date: 01-Feb-2020 09:45) Posted: Results likely to be out around mid March 2020. Results likely to be good. The medical devices sector had been growing. See below: Revenue from medical devices. 2017 - $24.9 mil 2018 - $30.4 mil 2019 - $45.0 mil With the health issues in China the demand for medical devices will grow, especially when new hospitals are put up in addition to the existing ones. Company is well represented in China, see earlier posting. The medical devices for Airway Management and Respiratory are likely yo see huge demands. Just sharing. Dyodd josephyeo      ( Date: 31-Jan-2020 11:05) Posted: This one has been profitable for many years n give excellent dividend. See below: 3+1 reasons why i am vested in this counter: 1. excellent dividend yield full year dividend 0.75 cts, price 9.0 cts ... yield 8.3% 2. low valuation on profit of $4.2 mil against market cap of $45.6 mil, the p/e is 10.8 X. This is relatively low considering the fact that it has a growing medical devices sector n its high dividend yield 3. its likely to be a growth company Its efforts in the expansion of the medical devices segment seem to bear fruits. It has widened its customer base, introduce more products and gone into more segments of the medical industry. Example, they are now in Airway Management, Respiratory, Endoscopy, Drug Delivery and Vascular. Its also in different locations. 4. wuhan virus the wuhan virus is actually an add-on. I was already keen in the counter before the wuhan virus issue, As company is thinly traded, this counter is not for punters/traders. Its more for long term holder or dividend investors. Just sharing. Dyodd

 

I entered at 25 hahaha jialat lah now 103 + no volume

wiltay      ( Date: 03-Feb-2020 09:36) Posted: Just be patient 😄 😎 Casilb      ( Date: 03-Feb-2020 09:07) Posted: 😴 😴 😴

 

Just be patient 😄 😎

Casilb      ( Date: 03-Feb-2020 09:07) Posted: 😴 😴 😴

 

😴 😴 😴

 

The stock is currently at overbought position.

Be careful.

 

Being in a market for a number of years does not mean anything.
How significant is the market to the company ?
How many percent of revenue it contributed ?

josephyeo      ( Date: 03-Feb-2020 00:07) Posted: They have been in China for a number of years. They are represented by 2 companies. See below: A quote from company' s annual report: The design, development and manufacture of sterile and non-sterile medical devices through our wholly-owned subsidiaries, - Forefront Medical Technology (Pte) Ltd and - Forefront Medical Investment Pte. Ltd. in Singapore - Forefront (Xiamen) Medical Devices Co., Ltd and - Forefront Medical Technology (Jiangsu) Co., Ltd in China - and 81% owned subsidiary, XentiQ (Pte.) Ltd. in Singapore.

 

They have been in China for a number of years. They are represented by 2 companies. See below:

A quote from company' s annual report:

The design, development and manufacture of sterile and non-sterile medical devices through our wholly-owned subsidiaries,
- Forefront Medical Technology (Pte) Ltd and
- Forefront Medical Investment Pte. Ltd. in Singapore
- Forefront (Xiamen) Medical Devices Co., Ltd and
- Forefront Medical Technology (Jiangsu) Co., Ltd in China
- and 81% owned subsidiary, XentiQ (Pte.) Ltd. in Singapore.

 

How well positioned ? Care to share ?

josephyeo      ( Date: 02-Feb-2020 00:48) Posted: Vicplas is well positined in China. Vicplas is well positioned in China. With the outbreak of the wuhan virus, i expect the sales of the medical devices to surge meaningfully. In the last financial year, the medical devices contributed a profit of $2.8 mil against a total profit of $4.2 mil. Any upsurge in demand will imply an upsurge in profitability. The company being in the Airway Management n Respiratory devices sector, is likely to see a huge invcease in demand. Just my guess. Just sharing. Dyodd.

 

http://bedokianportfolio.blogspot.com/2020/02/the-coronavirus-outbreak-what-to-do-as.html?m=1

 

Vicplas is well positined in China.
Vicplas is well positioned in China. With the outbreak of the wuhan virus, i expect the
sales of the medical devices to surge meaningfully. In the last financial year, the
medical devices contributed a profit of $2.8 mil against a total profit of $4.2 mil.
Any upsurge in demand will imply an upsurge in profitability.

The company being in the Airway Management n Respiratory devices sector,
is likely to see a huge invcease in demand. Just my guess.

Just sharing. Dyodd.

 

Medical devices profit $2.8 mil

Full year results show that the medical devices sector contributed
$2.8 mil profit out of a total of $4.2 mil.
This implies that growth in this sector will contribute substantially to this year profit.

Just sharing. Dyodd.

 

https://www.straitstimes.com/asia/east-asia/wuhan-virus-chinese-goes-full-throttle-to-manufacture-masks-in-virus-fight

 

I think it is expanding its medical production facility..
It shld look into produce mask , although mask is a low value and low margin product during normal time, but in a virus outbreak, the margin can be > 100%
Cld it be the nxt medical stock to shine?
So it needs some bb to notice and put in some volume...
During the sars outbreak yrs ago , medical stock like glove go up...
But this is not a contra stock, volume is pretty low , as the dividend not bad, so most shareholder just hold it..
If the medical segment outgrow the pipe segment by 30 % each yr , the revenue and profit may also grow btw 5% to 20%...
If the company not confident, it wont give out so high dividend..
And china now wld spend more on healthcare sector as to ready for any outbreak ..whether sars , wuhan or han outbreak, they are going to be prepared in future

 

Small cap pe abt 12x.
Assume 5mio net profit.
About 12c. Fairly value.

 

Results likely to be out around mid March 2020.
Results likely to be good. The medical devices sector had been growing.
See below:

Revenue from medical devices.
2017 - $24.9 mil
2018 - $30.4 mil
2019 - $45.0 mil

With the health issues in China the demand for medical devices will grow, especially
when new hospitals are put up in addition to the existing ones.

Company is well represented in China, see earlier posting. The medical devices
for Airway Management and Respiratory are likely yo see huge demands.

Just sharing. Dyodd

josephyeo      ( Date: 31-Jan-2020 11:05) Posted: This one has been profitable for many years n give excellent dividend. See below: 3+1 reasons why i am vested in this counter: 1. excellent dividend yield full year dividend 0.75 cts, price 9.0 cts ... yield 8.3% 2. low valuation on profit of $4.2 mil against market cap of $45.6 mil, the p/e is 10.8 X. This is relatively low considering the fact that it has a growing medical devices sector n its high dividend yield 3. its likely to be a growth company Its efforts in the expansion of the medical devices segment seem to bear fruits. It has widened its customer base, introduce more products and gone into more segments of the medical industry. Example, they are now in Airway Management, Respiratory, Endoscopy, Drug Delivery and Vascular. Its also in different locations. 4. wuhan virus the wuhan virus is actually an add-on. I was already keen in the counter before the wuhan virus issue, As company is thinly traded, this counter is not for punters/traders. Its more for long term holder or dividend investors. Just sharing. Dyodd

 

Anyway it has not gone up by much ie 10c to now 12c ...compare to medtech from 5c to 21c...
So its reasonably priced with nice dividend....
the shareholders all cheering the 'high' dividend , u see in the minutes of the last agm, the shareholders all clapping after the dividend is maintain & increased for past 3 years
thats why there's very little or not much sellers , all holding for dividend.. comtributing to lesser volume
Prices may adjust itself depending on news of the corona wuhan factor ,etc
But nothing has change fundamentally

Casilb      ( Date: 01-Feb-2020 08:28) Posted: Ahh , okok . Sad.. thought this stock would speculate like the rest  Wind22i      ( Date: 01-Feb-2020 08:17) Posted: Well i think not much contra player in this due to low volume.. so some cld just hold and take dividend. and has good fundamental

 

Ahh , okok . Sad.. thought this stock would speculate like the rest 

Wind22i      ( Date: 01-Feb-2020 08:17) Posted: Well i think not much contra player in this due to low volume.. so some cld just hold and take dividend. and has good fundamental Casilb      ( Date: 01-Feb-2020 07:58) Posted: So its gonna get sold down like other counters next week??  is there any support

 

Well i think not much contra player in this due to low volume.. so some cld just hold and take dividend.
and has good fundamental

Casilb      ( Date: 01-Feb-2020 07:58) Posted: So its gonna get sold down like other counters next week??  is there any support ? TA_Expert      ( Date: 01-Feb-2020 01:08) Posted: Based on chart, it is super overbought.

 

So its gonna get sold down like other counters next week?? 

is there any support ?

TA_Expert      ( Date: 01-Feb-2020 01:08) Posted: Based on chart, it is super overbought.

 

Based on chart, it is super overbought.